pembrolizumab,gemcitabine
merck
['pembro', 'hcrn gu14-188', 'urothelial', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)']
hcrn gu14-188: phase ib/ii study of neoadjuvant pembrolizumab and chemotherapy for t2-4an0m0 urothelial cancer #gu23 
Medical Oncologist - Urologic Oncology. Hospital Universitario La Paz - IdiPAZ, Madrid